Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of celecoxib 200 mg capsules in healthy Thai volunteers
TCTR20170104001Phase 1Completed
- Sponsor
- International Bio Service
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of celecoxib in pain and inflammation (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax, AUC0-tlast and 2 more. Started Mar 2017; status: completed.
02
Drugs
celecoxib
03
Conditions
paininflammation
Beyond the preview
Go deeper on TCTR20170104001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170104001.